Genome-wide transcriptional effects of the anti-cancer agent camptothecin
about
Transcription Blockage Leads to New BeginningsIntegrative RNA-seq and microarray data analysis reveals GC content and gene length biases in the psoriasis transcriptomeRate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications.Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition.Topoisomerase 1 inhibition reversibly impairs synaptic function.DNA repair and recovery of RNA synthesis following exposure to ultraviolet light are delayed in long genes.PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.Dynamic Effects of Topoisomerase I Inhibition on R-Loops and Short Transcripts at Active PromotersIdentification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assayIdentifying transcription start sites and active enhancer elements using BruUV-seq.Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitorZylka et al. reply.Variola type IB DNA topoisomerase: DNA binding and supercoil unwinding using engineered DNA minicircles.Identification of early gene expression changes in primary cultured neurons treated with topoisomerase I poisonsTotal RNA-seq to identify pharmacological effects on specific stages of mRNA synthesis.Camptothecin inhibits the progression of NPC by regulating TGF-β-induced activation of the PI3K/AKT signaling pathway.PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin
P2860
Q26801362-844DA835-ECE8-4991-BE9F-696E5BA30E89Q30824606-D2CBB047-E9C8-486B-B14E-0E30515BD8CBQ33657722-59A9F1B0-EA0C-4591-86EC-10DDB7356207Q34059605-2D871C2A-F120-42CE-A852-E9C1F3AF13F2Q34661252-A7655A18-D4C5-42C8-BF27-F7D63411B885Q35171650-3974FF21-4457-4495-89FF-B6B2655F27F7Q35832219-6A81FCA9-1A5D-4125-A93D-DC0EE5F2E3A3Q35897671-9AB2E02E-315C-4BE7-A774-204385EAA9D9Q36275846-6B6C3CEE-9A31-4436-95CC-5F667D8A0B9BQ36363834-29CA3947-A421-4DB2-B43E-836C6D90D54DQ37329941-818A69BD-2F82-4C1A-A525-D1922AFFF73FQ42149971-52AB5ADB-A20A-4009-8291-FC7D74A16D84Q42211325-ADFD092E-EE22-44A7-9813-C9408D0573A6Q42388000-5D051D14-E818-4D00-B101-C7BD589D794BQ42775893-2A47440E-4CEE-41BA-B8B8-0FA72813CD6DQ55348670-4D3FB5F7-D53E-4935-9E5D-1C5026C11337Q58747369-C66A3292-98DF-43ED-A443-2BA33346F804
P2860
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@ast
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@en
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@nl
type
label
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@ast
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@en
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@nl
prefLabel
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@ast
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@en
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@nl
P2093
P2860
P3181
P1433
P1476
Genome-wide transcriptional effects of the anti-cancer agent camptothecin
@en
P2093
Artur Veloso
Benjamin Biewen
Brian Magnuson
Jayendra Prasad
Leonardo Carmo de Andrade Lima
Mats Ljungman
Michelle T Paulsen
Thomas E Wilson
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0078190
P407
P577
2013-01-01T00:00:00Z